Unique metabolomic signature associated with hepatorenal dysfunction and mortality in cirrhosis
Ayse L. Mindikoglu(Baylor College of Medicine), Cristian Coarfa(Baylor College of Medicine), Sridevi Devaraj(Baylor College of Medicine), Robert P. Mohney(Owlstone Medical (United Kingdom)), David Sheikh‐Hamad(Baylor College of Medicine), Antone R. Opekun(Baylor College of Medicine), Jean‐Pierre Raufman(University of Maryland, Baltimore), John M. Vierling(Baylor College of Medicine), Robert H. Christenson(University of Maryland, Baltimore), Matthew R. Weir(University of Maryland, Baltimore), Charles D. Howell(University of Maryland, Baltimore), William R. Hutson(University of Pittsburgh), Lesley A. Inker(Tufts Medical Center), Hocine Tighiouart(Tufts University), Abbas Rana(Michael E. DeBakey VA Medical Center), Prasun K. Jalal(Baylor College of Medicine), Laurence S. Magder(University of Maryland, Baltimore), Stephen L. Seliger(University of Maryland, Baltimore), John A. Goss(Baylor College of Medicine), Thomas C. Dowling(Ferris State University), Gagan Sood(Baylor College of Medicine), Nagireddy Putluri(Baylor College of Medicine)
Cited by 79
Related Papers
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
|Journal of the American College of Cardiology|2020|11.1k
Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin C
|New England Journal of Medicine|2012|4.1k
Decline in Estimated Glomerular Filtration Rate and Subsequent Risk of End-Stage Renal Disease and Mortality
|JAMA|2014|982
Cystatin C versus Creatinine in Determining Risk Based on Kidney Function
|New England Journal of Medicine|2013|968